Topics

Athersys, Inc. Company Profile

23:46 EST 26th February 2020 | BioPortfolio

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company is developing MultiStem®, a patented, adult-derived "off-the-shelf" stem cell product platform for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation and oncology treatment support, ischemic stroke, and inflammatory bowel disease. The Company is also developing a portfolio of other therapeutic programs, including orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE®). Athersys has forged several key strategic alliances and collaborations with leading pharmaceutical and biotechnology companies, as well as world-renowned research institutions in the United States and Europe to further develop its platform and products. More information is available at www.athersys.com.


News Articles [14 Associated News Articles listed on BioPortfolio]

Athersys Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Stock option award offered as inducement to Ivor Macleod, new Chief Financial Officer of Athersys Athersys, Inc. (“Athersys” or the “Company”) (NASDAQ: ATHX) announced today that, as previou...

Athersys to Host Year-End 2019 Financial Results Call

Athersys, Inc. (Nasdaq: ATHX) will release its year-end 2019 financial results at approximately 4:00 PM Eastern Time on Monday, March 16, 2020, and will host a conference call shortly thereafter at 4...

Athersys: Potential Upside

Athersys Reports Third Quarter 2019 Results

CLEVELAND, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended September 30, 2019. Highlights of the third quart...

Athersys Reports Second Quarter 2019 Results

CLEVELAND, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today its financial results for the three months ended June 30, 2019. Highlights of the second quarter of 2...

Athersys, Inc. 2019 Q2 - Results - Earnings Call Slides

Athersys Provides Update on One-Year ARDS Study Data

CLEVELAND, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ: ATHX) announced today the one-year follow-up summary results from its exploratory clinical study of the intravenous admini...

Athersys, Inc. 2019 Q3 - Results - Earnings Call Presentation

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

Athersys Incorporated

Athersys is a biotechnology company engaged in the research and development of products for the treatment and diagnosis of genetic and immunologic disorders. The company has a core expertise in the f...

Athersys

Athersys is a biopharmaceutical company engaged in the development and commercialization of therapeutic products that treat significant and life-threatening diseases.As represented by its name, (Ather...

Athersys, Inc.

Athersys is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The Company ...

More Information about "Athersys, Inc." on BioPortfolio

We have published hundreds of Athersys, Inc. news stories on BioPortfolio along with dozens of Athersys, Inc. Clinical Trials and PubMed Articles about Athersys, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Athersys, Inc. Companies in our database. You can also find out about relevant Athersys, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record